UnitedHealth Group earnings next week may signal whether health insurance companies are getting a handle on rising costs dragging down the industry.
Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, side effects and when it could reach patients.
Serially cloned mice hit a genetic “dead end” by generation 58, underscoring that sex evolved for variation, purging harmful mutations and keeping lineages viable.
Programmable cell‑like particles seek out drug‑resistant bacteria, inject lethal payloads, and spare beneficial microbes.
Healthcare initiatives being proposed like Patients’ Bill of Rights offer a roadmap for Democrats’ priorities, with midterms looming and a presidential election in 2028.
Trump administration is considering auto-enrollment for Medicare enrollees in Medicare Advantage. This suggests a preference for the program over traditional Medicare.
Prior authorization forces doctors to spend 13 hours a week fighting insurers. New federal rules are changing that—here’s what you need to know.
Better healthcare outcomes and lower costs begin with subtraction, not addition. Here’s why less is more when it comes to American medicine.
A public health expert breaks down the details of the CDC delaying reporting of COVID-19 vaccine benefits, including study methodology issues.
Advances in nerve regeneration. Tricking AI into believing in a fake disease. Mapping the Moon. All that and more in this week’s edition of The Prototype.